CEO Doubles Down After $13M Director Buy
Second insider in 12 hours. CEO Paul LaViolette drops $295k at $19.69 while the stock sits oversold with RSI at 40. Healthcare's getting crushed across the board, but two PLSE insiders see something different. Insiders on this name have been right 6 out of 10 times historically with solid alpha generation.
The Filing
| Ticker | PLSE |
| Company | PULSE BIOSCIENCES, INC. |
| Insider | Paul Laviolette, Chief Executive Officer |
| Buy amount | $295,350 |
| Filing date | May 11, 2026 |
| Conviction | Interesting · 56/100 |
| Setup type | Oversold Bounce |
Ultimate members received this analysis in real time.